Int. J. Radiat. Oncol. Biol. Phys.
A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer.
Related Questions
Given the multiple retrospective studies showing benefit to higher BED fractionation schedules (most recently, http://www.redjournal.org/article/S0360...
New comment by Radiation Oncologist at Abramson Cancer Center, University of Pennsylvania ( January 26, 2018)
this is another great paper from the Cleveland clinic that helps to to determine the balance between optimal local control and toxicity for SBRT. Previously, they were one of...
Now that RTOG 0915 shows 5 year data with no difference in OS, DFS, and toxicity, should single tx be routinely offered? Are there specific pati...
New comment by Radiation Oncologist at Centura Health ( December 5, 2022)
The only requirements to be eligible for 0915 were <5 cm and non-central location. The study would non-scientifically argue that you gain only a small reduction in grade 1-...